ProGRP was proven to be an effective complementary tumor marker for MTC diagnosis, and when combined with CT or CEA, it can more accurately differentiate MTC from other thyroid cancers in the early stages.20 Here, CEACAM5 is linked to medullary thyroid gland carcinoma.